CollPlant Biotechnologies (CLGN) Inventory (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Inventory of $573000.0 for Q4 2025, up 3.62% on a QoQ basis from $553000.0 in Q2 2025, and down 99.87% year-over-year from $440.0 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Inventory (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Inventory history runs 9 years deep, the most recent figure standing at $573000.0 for Q4 2025.
- Quarterly Inventory fell 99.87% year-over-year to $573000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $573000.0 (down 99.87% YoY) and the FY2025 annual result came in at $573000.0, down 99.87% from the prior year.
- Inventory was $573000.0 for Q4 2025 at CollPlant Biotechnologies, up from $553000.0 in the prior quarter.
- Across five years, Inventory topped out at $1081.0 billion in Q4 2021 and bottomed at $439000.0 in Q2 2024.
- A 5-year average of $60.4 billion and a median of $1.5 million in 2022 frame the typical range for Inventory.
- Annual changes were most pronounced in 2021 — Inventory soared 85657586.21% — and 2023, when it slumped 99.95%.
- CollPlant Biotechnologies' Inventory stood at $1081.0 billion in 2021, then sank by 99.87% to $1.4 billion in 2022, then slumped by 99.95% to $714000.0 in 2023, then jumped by 61524.65% to $440.0 million in 2024, then sank by 99.87% to $573000.0 in 2025.
- Business Quant data shows CLGN's Inventory at $573000.0 in Q4 2025, $553000.0 in Q2 2025, and $440.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | 681.59 Mn |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | 1.77 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 3.10 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | 371.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 84.03 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 573,000.00 |
| Jun 30, 2025 | 553,000.00 |
| Dec 31, 2024 | 440.00 Mn |
| Sep 30, 2024 | 454.00 Mn |
| Jun 30, 2024 | 439,000.00 |
| Mar 31, 2024 | 645.00 Mn |
| Dec 31, 2023 | 714,000.00 |
| Sep 30, 2023 | 1.50 Bn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.78 Mn |
| Dec 31, 2022 | 1.43 Bn |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1,081.00 Bn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 940,000.00 |
| Mar 31, 2021 | 1.28 Bn |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 967,000.00 |